These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 3861127

  • 1. Opiate antagonistic function of cholecystokinin in analgesia and energy balance systems.
    Faris PL.
    Ann N Y Acad Sci; 1985; 448():437-47. PubMed ID: 3861127
    [Abstract] [Full Text] [Related]

  • 2. Role of cholecystokinin in the control of nociception and food intake.
    Faris PL.
    Prog Clin Biol Res; 1985; 192():159-66. PubMed ID: 4080709
    [Abstract] [Full Text] [Related]

  • 3. Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide.
    Watkins LR, Kinscheck IB, Mayer DJ.
    Brain Res; 1985 Feb 18; 327(1-2):169-80. PubMed ID: 3838690
    [Abstract] [Full Text] [Related]

  • 4. Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates.
    Watkins LR, Kinscheck IB, Kaufman EF, Miller J, Frenk H, Mayer DJ.
    Brain Res; 1985 Feb 18; 327(1-2):181-90. PubMed ID: 3838691
    [Abstract] [Full Text] [Related]

  • 5. Morphine-induced analgesia in the rat paw pressure test is blocked by CCK and enhanced by the CCK antagonist MK-329.
    O'Neill MF, Dourish CT, Iversen SD.
    Neuropharmacology; 1989 Mar 18; 28(3):243-7. PubMed ID: 2725851
    [Abstract] [Full Text] [Related]

  • 6. Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia.
    Faris PL, Komisaruk BR, Watkins LR, Mayer DJ.
    Science; 1983 Jan 21; 219(4582):310-2. PubMed ID: 6294831
    [Abstract] [Full Text] [Related]

  • 7. Morphine analgesia potentiated but tolerance not affected by active immunization against cholecystokinin.
    Faris PL, McLaughlin CL, Baile CA, Olney JW, Komisaruk BR.
    Science; 1984 Dec 07; 226(4679):1215-7. PubMed ID: 6505689
    [Abstract] [Full Text] [Related]

  • 8. Chronic administration of cholecystokinin antagonists reverses the enhancement of spinal morphine analgesia induced by acute pretreatment.
    Kellstein DE, Mayer DJ.
    Brain Res; 1990 May 21; 516(2):263-70. PubMed ID: 2364292
    [Abstract] [Full Text] [Related]

  • 9. Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenin inflammation.
    Stanfa LC, Dickenson AH.
    Br J Pharmacol; 1993 Apr 21; 108(4):967-73. PubMed ID: 8485635
    [Abstract] [Full Text] [Related]

  • 10. The role of CCK caerulein, and CCK antagonists in nociception.
    Baber NS, Dourish CT, Hill DR.
    Pain; 1989 Dec 21; 39(3):307-328. PubMed ID: 2694075
    [Abstract] [Full Text] [Related]

  • 11. The nature of conditioned anti-analgesia: spinal cord opiate and anti-opiate neurochemistry.
    Wiertelak EP, Yang HY, Mooney-Heiberger K, Maier SF, Watkins LR.
    Brain Res; 1994 Jan 21; 634(2):214-26. PubMed ID: 8131071
    [Abstract] [Full Text] [Related]

  • 12. Stress-induced analgesia in mice: evidence for interaction between endocannabinoids and cholecystokinin.
    Kurrikoff K, Inno J, Matsui T, Vasar E.
    Eur J Neurosci; 2008 Apr 21; 27(8):2147-55. PubMed ID: 18412633
    [Abstract] [Full Text] [Related]

  • 13. Behavioral evidence for cholecystokinin-opiate interactions in neonatal rats.
    Weller A, Blass EM.
    Am J Physiol; 1988 Dec 21; 255(6 Pt 2):R901-7. PubMed ID: 3202224
    [Abstract] [Full Text] [Related]

  • 14. Reversal of spinal cord non-opiate analgesia by conditioned anti-analgesia in the rat.
    Watkins LR, McGorry M, Schwartz B, Sisk D, Wiertelak EP, Maier SF.
    Pain; 1997 Jul 21; 71(3):237-47. PubMed ID: 9231866
    [Abstract] [Full Text] [Related]

  • 15. Cholecystokinin antianalgesia: safety cues abolish morphine analgesia.
    Wiertelak EP, Maier SF, Watkins LR.
    Science; 1992 May 08; 256(5058):830-3. PubMed ID: 1589765
    [Abstract] [Full Text] [Related]

  • 16. Circuitry underlying antiopioid actions of cholecystokinin within the rostral ventromedial medulla.
    Heinricher MM, McGaraughty S, Tortorici V.
    J Neurophysiol; 2001 Jan 08; 85(1):280-6. PubMed ID: 11152727
    [Abstract] [Full Text] [Related]

  • 17. Extracellular cholecystokinin levels in the rat spinal cord following chronic morphine exposure: an in vivo microdialysis study.
    Lucas GA, Hoffmann O, Alster P, Wiesenfeld-Hallin Z.
    Brain Res; 1999 Mar 06; 821(1):79-86. PubMed ID: 10064790
    [Abstract] [Full Text] [Related]

  • 18. Role of cholecystokinin and opioid peptides in control of food intake.
    Baile CA, McLaughlin CL, Della-Fera MA.
    Physiol Rev; 1986 Jan 06; 66(1):172-234. PubMed ID: 2868468
    [Abstract] [Full Text] [Related]

  • 19. [Potentiation of morphine- and ohmefentanyl-induced analgesia by cholecystokinin receptor antagonists in rat].
    Zhou Y, Sun YH, Han JS.
    Sheng Li Xue Bao; 1993 Jun 06; 45(3):255-61. PubMed ID: 8235725
    [Abstract] [Full Text] [Related]

  • 20. The roles of nerve growth factor and cholecystokinin in the enhancement of morphine analgesia in a rodent model of central nervous system inflammation.
    Xanthos DN, Kumar N, Theodorsson E, Coderre TJ.
    Neuropharmacology; 2009 Mar 06; 56(3):684-91. PubMed ID: 19103210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.